罗格列酮对高脂血症大鼠血管平滑肌细胞凋亡的影响及机制探讨
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

湖南省自然科学基金资助项目(06jj5045)


The Effect of Rosiglitazone on Apoptosis of Vascular Smooth Musle Cell of Rat and Mechanism Exploration
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的观察罗格列酮对高脂血症大鼠血管平滑肌细胞凋亡及磷酸化Smad2/3表达的影响。方法高脂饮食复制SD大鼠高脂血症模型,酶消化法原代提取SD大鼠胸主动脉平滑肌细胞进行体外培养,取5~8代细胞进行实验。无血清培养24h后:实验一分为4组:①对照组,②罗格列酮组(本实验所用罗格列酮均为100μmol/L),③罗格列酮+过氧化物酶体增生激活受体γ(PPAR-γ)阻断剂GW9662组,④罗格列酮+抗转化生长因子β1(anti-TGF-β1)组,分别用Westernblot于1h检测磷酸化Smad2/3水平,24h后流式细胞学检测细胞凋亡;实验二分2组:①对照组,②100μmol/L罗格列酮组,分别于0、0.5、1、2、6、12和24h,用Western-blot检测磷酸化Smad2/3水平。结果24h后罗格列酮组细胞凋亡率较对照组明显升高(P<0.05),罗格列酮+GW9662组和罗格列酮+抗转化生长因子β1组细胞凋亡率较罗格列酮组明显降低(P<0.05);罗格列酮处理后0.5hVSMCp-Smad2/3表达水平明显高于对照组(P<0.05),且1h达高峰(P<0.05),p-Smad2/3水平达到高峰后又较快下降(P<0.05);罗格列酮+GW9662组和罗格列酮+anti-TGF-β1组p-Smad2/3表达水平较罗格列酮组低(P<0.05)。结论罗格列酮可能通过激活过氧化物酶体增生激活受体γ,诱导血管平滑肌细胞磷酸化Smad2/3表达水平上调从而诱导血管平滑肌细胞凋亡。

    Abstract:

    Aim To observe the effect of rosiglitazone on apoptosis and expression of Phospho-Smad2/3 of thoracic aorta vascular smooth musle cell(VSMC)of hypercholesterol rat in vitro.Methods Primary cultures of rat VSMC were obtained enzymatically from dissociated hypercholesterol SD rat thoracic.Cells at passage five through eight were used in this experiment.After VSMC were serum-starved for 24 hours,they were randomly divided into two parts:part 1,cells were subdivided into four groups:①control group,②rosiglitazone group(concentration of rosiglitazone was 100umoll in this experiment),③rosiglitazone + GW9662 group,④rosiglitazone + anti-TGF-β1 group,the expression of p-Smad2/3 after 1 hour was detected by Western-blot.The apoptosis of VSMC was observed by flow cytometry after 24 hours;Part 2,cells were subdivided into two groups:①control group,②rosiglitazone group,expression level of p-Smad2/3 after 0,0.5,1,2,6,12,24 hours were detected by Western-blot.Results Our experiment show that the rate of apoptosis in VSMC treated with rosiglitazone was higher than control group(P<0.05)after 24 hours.The rate of apoptosis in VSMC in the groups treated with rosiglitazone + GW9662 or rosiglitazone + anti-TGF-β1 were higher than the group treated with rosiglitazone(P<0.05),from this we may conclude that GW9662 and anti-TGF-β1 would partly reverse the apoptosis of VSMC induced by rosiglitazone.The expression levels of p-Smad2/3 in the group treated with rosiglitazone were higher than the control group after 0.5 hour(P<0.05),and the expression level of p-Smad2/3 reached the highest in 1 hour(P<0.05)then decreased fast after top(P<0.05),from this we may conclude that rosiglitazone was able to induce VSMC expression p-Smad2/3.Furthermore,the levels of p-Smad2/3 in the group treated with rosiglitazone was higher than the groups treated with rosiglitazone + GW9662 or rosiglitazone + anti-TGF-β1,from this we may conclude that the GW9662 and anti-TGF-β1 both could partly reverse the expression levels of p-Smad2/3 in VSMC induced by rosiglitazone.Conclusion The apoptotic effect of rosiglitazone in VSMC would be mediated by a mechanism that includes the activation of PPAR-γ,inducing the apoptosis of VSMC by up-regulation of the expression level of the P-Smad2/3.

    参考文献
    相似文献
    引证文献
引用本文

刘厂辉,李建平,阳辉.罗格列酮对高脂血症大鼠血管平滑肌细胞凋亡的影响及机制探讨[J].中国动脉硬化杂志,2010,18(3):199~202.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2009-09-07
  • 最后修改日期:2009-11-20
  • 录用日期:
  • 在线发布日期: